These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 32678972)
1. New psychoactive substances on dark web markets: From deal solicitation to forensic analysis of purchased substances. Jurásek B; Čmelo I; Svoboda J; Čejka J; Svozil D; Kuchař M Drug Test Anal; 2021 Jan; 13(1):156-168. PubMed ID: 32678972 [TBL] [Abstract][Full Text] [Related]
2. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"? Napoletano S; Basile G; Lo Faro AF; Negro F Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997 [TBL] [Abstract][Full Text] [Related]
3. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. Van Hout MC; Hearne E Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812 [TBL] [Abstract][Full Text] [Related]
4. A market on both "sides" of the law: The use of the hidden web for the sale of new psychoactive substances. Wadsworth E; Drummond C; Kimergård A; Deluca P Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28617997 [TBL] [Abstract][Full Text] [Related]
5. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time. Tzanetakis M Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105 [TBL] [Abstract][Full Text] [Related]
6. HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances. Mardal M; Andreasen MF; Mollerup CB; Stockham P; Telving R; Thomaidis NS; Diamanti KS; Linnet K; Dalsgaard PW J Anal Toxicol; 2019 Aug; 43(7):520-527. PubMed ID: 31095696 [TBL] [Abstract][Full Text] [Related]
7. Systematic analytical characterization of new psychoactive substances: A case study. Lobo Vicente J; Chassaigne H; Holland MV; Reniero F; Kolář K; Tirendi S; Vandecasteele I; Vinckier I; Guillou C Forensic Sci Int; 2016 Aug; 265():107-15. PubMed ID: 26874735 [TBL] [Abstract][Full Text] [Related]
8. The Presence of New Psychoactive Substances in a Tor Network Marketplace Environment. Dolliver DS; Kuhns JB J Psychoactive Drugs; 2016; 48(5):321-329. PubMed ID: 27660913 [TBL] [Abstract][Full Text] [Related]
9. Investigating the appearance of new psychoactive substances in South Australia using wastewater and forensic data. Bade R; Stockham P; Painter B; Celma A; Bijlsma L; Hernandez F; White JM; Gerber C Drug Test Anal; 2019 Feb; 11(2):250-256. PubMed ID: 30129282 [TBL] [Abstract][Full Text] [Related]
10. The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS. Wadsworth E; Drummond C; Deluca P Brain Sci; 2018 Mar; 8(3):. PubMed ID: 29547520 [TBL] [Abstract][Full Text] [Related]
11. New psychoactive substances: An actual problem or an overestimated phenomenon? Vaiano F; Pascali JP; Bertol E Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421 [TBL] [Abstract][Full Text] [Related]
12. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users. Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L Int J Drug Policy; 2016 Sep; 35():32-7. PubMed ID: 26872846 [TBL] [Abstract][Full Text] [Related]
13. Target and suspect screening of (new) psychoactive substances in South Korean wastewater by LC-HRMS. Lee HJ; Oh JE Sci Total Environ; 2023 Jun; 875():162613. PubMed ID: 36871726 [TBL] [Abstract][Full Text] [Related]
14. Using internet snapshot surveys to enhance our understanding of the availability of the novel psychoactive substance 4-methylaminorex and 4,4'-dimethylaminorex. Nizar H; Dargan PI; Wood DM J Med Toxicol; 2015 Mar; 11(1):80-4. PubMed ID: 25167967 [TBL] [Abstract][Full Text] [Related]
15. Screening strategy for ketamine-based new psychoactive substances using fragmentation characteristics from high resolution mass spectrometry. Gao J; Xu B; Yang R; Zhang H Forensic Sci Int; 2023 Jun; 347():111677. PubMed ID: 37028217 [TBL] [Abstract][Full Text] [Related]
16. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens. Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224 [TBL] [Abstract][Full Text] [Related]
17. Using biomarkers in wastewater to monitor community drug use: a conceptual approach for dealing with new psychoactive substances. Reid MJ; Baz-Lomba JA; Ryu Y; Thomas KV Sci Total Environ; 2014 Jul; 487():651-8. PubMed ID: 24412561 [TBL] [Abstract][Full Text] [Related]
18. Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Bäckberg M; Jönsson KH; Beck O; Helander A Drug Test Anal; 2018 Feb; 10(2):340-349. PubMed ID: 28600832 [TBL] [Abstract][Full Text] [Related]
19. New psychoactive substances in oral fluid of drivers around a music festival in south-west France in 2017. Richeval C; Dumestre-Toulet V; Wiart JF; Vanhoye X; Humbert L; Nachon-Phanithavong M; Allorge D; Gaulier JM Forensic Sci Int; 2019 Apr; 297():265-269. PubMed ID: 30851602 [TBL] [Abstract][Full Text] [Related]
20. A snapshot on NPS in Italy: Distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013-2015. Odoardi S; Romolo FS; Strano-Rossi S Forensic Sci Int; 2016 Aug; 265():116-20. PubMed ID: 26874736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]